Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
ARAY	ACCURAY INC	United States	$217.18M	99,168,765	60.78%	39.22%	Net Selling	Net Selling
COCH	ENVOY MEDICAL INC	United States	$101.53M	19,599,982	8.40%	73.05%	Net Buying
BACK	IMAC HOLDINGS INC	United States	$4.50M	1,148,321	2.59%	97.41%
VERO	VENUS CONCEPT INC	Canada	$4.35M	6,355,230	1.59%	98.41%
AEON	AEON BIOPHARMA INC	United States	$191.59M	37,788,858	22.93%	61.40%	Net Selling
MD	PEDIATRIX MEDICAL GROUP INC	United States	$760.47M	84,122,979	95.37%	4.63%	Net Selling	Net Selling
SER	SERINA THERAPEUTICS INC	United States	$22.98M	2,500,664	12.90%	87.10%
CYH	COMMUNITY HEALTH SYSTEMS INC	United States	$471.10M	138,966,388	60.92%	39.08%	Net Buying	Net Selling
JAGX	JAGUAR HEALTH INC	United States	$49.72M	276,216,260	0.45%	3.48%
ARMP	ARMATA PHARMACEUTICALS INC	United States	$99.77M	36,148,539	1.55%	98.45%
ASLN	ASLAN PHARMACEUTICALS LTD	Singapore	$7.30M	439,926,480	0.79%	0.00%
TRIB	TRINITY BIOTECH PLC	Ireland	$14.03M	153,310,280	3.93%	0.00%
NVAX	NOVAVAX INC	United States	$572.41M	139,953,143	55.43%	19.60%	Net Selling	Net Selling
AXDX	ACCELERATE DIAGNOSTICS INC	United States	$20.15M	21,664,387	3.44%	96.56%	Net Buying	Net Selling
BHC	BAUSCH HEALTH COMPANIES INC	Canada	$3.18B	365,411,953	71.87%	28.13%	Net Selling	Net Selling
CSBR	CHAMPIONS ONCOLOGY INC	United States	$68.24M	13,593,767	1.90%	98.10%	Net Buying
PSTV	PLUS THERAPEUTICS INC	United States	$7.23M	4,276,082	0.60%	99.40%	Net Buying
ALUR	ALLURION TECHNOLOGIES INC	United States	$91.88M	47,852,203	15.87%	16.54%	Net Buying
MRAI	MARPAI INC	United States	$22.46M	10,300,548	2.30%	79.86%	Net Buying	Net Buying
MMA	ALTA GLOBAL GROUP LTD	Australia	N/A	10,223,079	0.00%	0.00%
ATRA	ATARA BIOTHERAPEUTICS INC	United States	$82.36M	119,359,230	54.24%	11.13%	Net Buying	Net Selling
CNTG	CENTOGENE NV	Germany	$13.49M	27,595,835	9.75%	0.00%
ELAN	ELANCO ANIMAL HEALTH INC	United States	$6.54B	492,970,011	90.53%	9.47%	Net Selling	Net Selling
EPRX	EUPRAXIA PHARMACEUTICALS INC	Canada	N/A	27,282,165	0.00%	0.00%
DHAI	DIH HOLDING US INC	United States	$17.70M	10,660,292	11.08%	88.92%
GRTX	GALERA THERAPEUTICS INC	United States	$10.12M	54,392,170	23.78%	57.19%	Net Selling	Net Selling
ELTX	ELICIO THERAPEUTICS INC	United States	$92.02M	10,235,469	3.25%	92.54%	Net Buying
YS	YS BIOPHARMA CO LTD	China	$74.45M	93,058,197	10.08%	0.00%
DRMA	DERMATA THERAPEUTICS INC	United States	$2.28M	6,660,840	4.01%	95.99%
MAIA	MAIA BIOTECHNOLOGY INC	United States	$58.81M	20,002,826	4.02%	22.12%	Net Buying	Net Buying
STRM	STREAMLINE HEALTH SOLUTIONS INC	United States	$18.88M	58,829,461	26.23%	73.77%	Net Buying	Net Buying
EHAB	ENHABIT INC	United States	$503.06M	50,155,940	97.96%	2.04%	Net Buying	Net Buying
ACXP	ACURX PHARMACEUTICALS INC	United States	$32.62M	15,757,102	6.93%	15.26%	Net Buying
HUMA	HUMACYTE INC	United States	$475.14M	119,083,728	14.97%	36.38%	Net Selling
RANI	RANI THERAPEUTICS HOLDINGS INC	United States	$335.05M	50,157,292	5.88%	51.66%	Net Buying
ZVSA	ZYVERSA THERAPEUTICS INC	United States	$3.79M	759,486	4.63%	95.37%
ENGN	ENGENE HOLDINGS INC	Canada	$675.51M	43,581,331	32.55%	27.91%	Net Buying	Net Buying
ICCC	IMMUCELL CORP	United States	$39.84M	7,750,864	13.45%	24.31%	Net Buying
OPGN	OPGEN INC	United States	$5.16M	10,013,524	1.28%	98.72%
HCWB	HCW BIOLOGICS INC	United States	$52.95M	37,823,394	2.82%	47.89%	Net Buying	Net Buying
CTLT	CATALENT INC	United States	$10.11B	180,737,675	79.66%	20.34%	Net Buying	Net Selling
IBIO	IBIO INC	United States	$6.13M	3,484,266	0.72%	99.28%	Net Selling
MOVE	MOVANO INC	United States	$46.66M	98,225,068	9.32%	10.19%	Net Buying
PBH	PRESTIGE CONSUMER HEALTHCARE INC	United States	$3.50B	49,649,288	69.04%	30.96%	Net Selling	Net Selling
UNCY	UNICYCIVE THERAPEUTICS INC	United States	$35.80M	34,756,436	37.49%	18.00%
QLGN	QUALIGEN THERAPEUTICS INC	United States	$1.83M	6,307,371	0.87%	99.13%
SKYE	SKYE BIOSCIENCE INC	United States	N/A	28,062,907	0.00%	100.00%	Net Buying	Net Buying
VCNX	VACCINEX INC	United States	$7.18M	1,231,602	18.31%	81.69%	Net Buying	Net Buying
OWLT	OWLET INC	United States	$37.29M	8,964,338	6.49%	93.51%	Net Selling	Net Selling
NRXP	NRX PHARMACEUTICALS INC	United States	$33.88M	9,569,978	6.23%	93.77%	Net Buying
SLS	SELLAS LIFE SCIENCES GROUP INC	United States	$82.15M	56,267,670	6.21%	13.47%	Net Selling
ALLR	ALLARITY THERAPEUTICS INC	United States	$451.06k	308,945	4.41%	95.59%
PTN	PALATIN TECHNOLOGIES INC	United States	$29.37M	16,136,640	8.26%	91.74%	Net Selling	Net Selling
OTLK	OUTLOOK THERAPEUTICS INC	United States	$109.70M	13,012,876	13.26%	86.74%	Net Buying	Net Buying
AKTX	AKARI THERAPEUTICS PLC	United States	$18.78M	15,847,391,523	0.00%	55.06%
NRSN	NEUROSENSE THERAPEUTICS LTD	Israel	$18.92M	15,379,042	0.92%	0.00%
TTOO	T2 BIOSYSTEMS INC	United States	$15.66M	5,512,332	0.51%	99.49%	Net Selling
ENSC	ENSYSCE BIOSCIENCES INC	United States	$4.28M	7,329,172	0.72%	57.99%
CLRB	CELLECTAR BIOSCIENCES INC	United States	$97.75M	32,260,510	26.67%	12.70%
CING	CINGULATE INC	United States	$4.41M	5,010,471	0.05%	99.95%	Net Buying	Net Buying
CNSP	CNS PHARMACEUTICALS INC	United States	$2.29M	10,634,932	2.97%	5.30%	Net Buying	Net Buying
CHRO	CHROMOCELL THERAPEUTICS CORP	United States	$9.40M	5,877,835	0.00%	47.70%	Net Buying	Net Buying
BCLI	BRAINSTORM CELL THERAPEUTICS INC	United States	$36.49M	68,341,857	5.79%	54.09%	Net Buying	Net Buying
AVAH	AVEANNA HEALTHCARE HOLDINGS INC	United States	$423.23M	192,378,711	29.14%	70.86%	Net Buying
ALZN	ALZAMEND NEURO INC	United States	$4.94M	6,866,846	0.97%	99.03%	Net Buying	Net Buying
ACHV	ACHIEVE LIFE SCIENCES INC	United States	$157.90M	34,251,911	7.96%	27.78%	Net Buying	Net Selling
APTO	APTOSE BIOSCIENCES INC	Canada	$19.18M	15,717,701	7.58%	67.78%	Net Buying
IVA	INVENTIVA SA	France	$169.38M	52,115,807	9.33%	0.00%
LSDI	LUCY SCIENTIFIC DISCOVERY INC	Canada	$1.34M	1,764,630	42.58%	57.42%
EUDA	EUDA HEALTH HOLDINGS LTD	Singapore	$48.56M	24,777,509	4.32%	39.56%
MDAI	SPECTRAL AI INC	United States	$32.31M	17,466,871	10.41%	76.42%	Net Buying
GALT	GALECTIN THERAPEUTICS INC	United States	$213.57M	61,903,672	8.36%	91.64%	Net Buying	Net Selling
KTRA	KINTARA THERAPEUTICS INC	United States	$5.82M	39,037,899	0.62%	27.90%
BGXX	BRIGHT GREEN CORP	United States	$38.03M	190,166,318	7.56%	67.06%	Net Buying	Net Buying
QTI	QT IMAGING HOLDINGS INC	United States	$17.58M	21,437,216	8.17%	91.83%	Net Buying	Net Buying
ATNF	180 LIFE SCIENCES CORP	United States	$1.53M	852,772	7.45%	92.55%	Net Buying
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	United States	$83.48M	27,918,560	18.78%	38.25%
HCTI	HEALTHCARE TRIANGLE INC	United States	$5.91M	4,649,909	0.02%	99.98%
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	Israel	$2.00M	1,453,970,784	0.03%	0.05%
CDT	CONDUIT PHARMACEUTICALS INC	United States	$234.04M	73,829,536	1.86%	73.61%
ANVS	ANNOVIS BIO INC	United States	$198.31M	11,011,299	10.94%	26.91%	Net Buying
OKYO	OKYO PHARMA LTD	United Kingdom	$37.56M	25,553,274	0.15%	99.85%	Net Buying
BCTX	BRIACELL THERAPEUTICS CORP	Canada	$34.68M	15,981,726	15.42%	12.34%
LIFW	MSP RECOVERY INC	United States	$141.37M	139,966,718	0.48%	13.43%	Net Buying	Net Selling
AMIX	AUTONOMIX MEDICAL INC	United States	$63.15M	18,793,974	0.00%	35.88%
VTVT	VTV THERAPEUTICS INC	United States	$81.17M	3,010,206	0.11%	99.89%	Net Buying	Net Buying
ONCO	ONCONETIX INC	United States	$2.61M	22,327,701	10.85%	21.37%
ONMD	ONEMEDNET CORP	United Kingdom	$13.48M	23,850,010	1.29%	27.05%	Net Selling
RNXT	RENOVORX INC	United States	$20.96M	16,865,975	1.96%	20.25%	Net Buying
ICU	SEASTAR MEDICAL HOLDING CORP	United States	$33.18M	75,419,458	1.23%	19.86%	Net Buying
INKT	MINK THERAPEUTICS INC	United States	$32.17M	34,699,056	2.85%	72.02%	Net Buying	Net Buying
NLSP	NLS PHARMACEUTICS LTD	Switzerland	$4.89M	35,671,780	16.35%	0.00%
OCEA	OCEAN BIOMEDICAL INC	United States	$45.76M	34,149,046	13.42%	75.32%
TVGN	TEVOGEN BIO HOLDINGS INC	United States	$153.25M	153,249,359	1.50%	98.50%	Net Selling
NKGN	NKGEN BIOTECH INC	United States	$36.72M	22,805,643	15.84%	84.16%	Net Buying
CLDI	CALIDI BIOTHERAPEUTICS INC	United States	$5.72M	35,538,034	5.35%	49.17%	Net Selling	Net Buying
PBM	PSYENCE BIOMEDICAL LTD	Canada	$11.50M	13,390,659	3.69%	66.53%	Net Selling

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	682	+1.20%	+1.13%	-9.62%	-22.18%	14.88x	5.85x	-68.98%	+2.75%	+21.30%	+91.76%	Strong Buy
Diagnostics & Research	66	+0.75%	+4.09%	-5.10%	-0.74%	38.49x	4.18x	-21.75%	+6.53%	+11.20%	+10.85%	Buy
Drug Manufacturers - General	17	+0.34%	+1.38%	-4.08%	+12.78%	159.81x	6.13x	+32.60%	+7.65%	+14.35%	+16.05%	Buy
Drug Manufacturers - Specialty & Generic	90	+0.98%	+2.24%	-2.72%	-6.94%	33.92x	2.09x	+11.56%	+2.78%	+5.22%	+37.77%	Strong Buy
Healthcare Plans	12	-0.85%	-2.11%	-4.78%	+3.59%	18.86x	2.91x	+20.02%	+6.15%	+14.19%	+16.44%	Buy
Health Information Services	61	+0.87%	+0.45%	-8.40%	-24.77%	72.49x	3.38x	+6.61%	+2.33%	+5.91%	+38.22%	Buy
Medical Care Facilities	50	-0.63%	-0.25%	-6.53%	+3.06%	-1.17x	4.49x	-87.35%	+6.17%	+13.08%	+19.34%	Buy
Medical Devices	154	+0.28%	+1.14%	-4.31%	-15.96%	28.63x	3.70x	+10.75%	+5.35%	+7.78%	+22.84%	Buy
Medical Distribution	9	+0.52%	+1.70%	-0.69%	+37.51%	26.24x	147.94x	+18.14%	+3.52%	+19.64%	+3.58%	Buy
Medical Instruments & Supplies	56	+1.23%	+1.70%	-4.37%	-11.53%	48.29x	3.53x	+11.70%	+7.83%	+10.36%	+20.52%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top healthcare stock with a Zen Score of 75, which is 50 points higher than the healthcare sector average of 25. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.72% over the past year, underperforming other healthcare stocks by -20 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.53% from Incyte's current stock price of $51.68.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -7.45% over the past year, overperforming other healthcare stocks by 3 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.33% from Harmony Biosciences Holdings's current stock price of $29.32.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -0.61% over the past year, overperforming other healthcare stocks by 10 percentage points.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.84%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.38%, which is 55 percentage points higher than the healthcare sector average of 2.84%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.95%, which is 9 percentage points higher than the healthcare sector average of 2.84%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.62% in the last day, and up 1.39% over the last week. Biodexa Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 79.31% yesterday.

Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -40.25% in the past year. It has underperformed other stocks in the healthcare sector by -30 percentage points.

2. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -53.19% in the past year. It has underperformed other stocks in the healthcare sector by -43 percentage points.

3. Orasure Technologies (NASDAQ:OSUR)

Orasure Technologies (NASDAQ:OSUR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Orasure Technologies has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Orasure Technologies's stock has dropped -19.88% in the past year. It has underperformed other stocks in the healthcare sector by -10 percentage points.

Are healthcare stocks a good buy now?

47.45% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.39% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 74.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.